The Short-term Impact of Symptom-defined COPD Exacerbation Recovery on Health Status and Lung Function

被引:11
作者
Murray, Lindsey T. [1 ]
Leidy, Nancy K. [1 ]
机构
[1] Evidera, Bethesda, MD USA
来源
CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION | 2018年 / 5卷 / 01期
关键词
COPD; exacerbations; EXACT; patient-reported outcomes; outcome measures; health status; lung function; OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; RESPIRATORY SYMPTOMS; NEUTROPHIL ELASTASE; CLINICAL-TRIALS; GLOBAL BURDEN; TIME-COURSE; TOOL EXACT; DIARY; QUESTIONNAIRE;
D O I
10.15326/jcopdf.5.1.2017.0166
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: This study examined the short-term effects of symptom-defined exacerbation recovery on health status and pulmonary function in moderate to severe chronic obstructive pulmonary disease (COPD) patients. Methods: Secondary analyses of pooled data from two 12-week Phase II international, randomized controlled trials using the EXAcerbations of Chronic Pulmonary Disease Tool (EXACT) to identify symptom-defined exacerbations were conducted. Recovery was categorized as recovered, unrecovered (persistent worsening), or censored. Multiple regression analyses were used to test the effect of recovery status on change in the St George's Respiratory Questionnaire (SGRQ) and forced expiratory volume in 1 second (FEV1) from baseline to Week 12. Evaluating Respiratory Symptom scale (E-RS) scores were used to evaluate change in stable-state respiratory symptoms from baseline to Week 12. Results: Of 1346 eligible patients, 414 (31%) experienced >= 1 symptom-defined exacerbation; 260 patients recovered from their events, 80 experienced an unrecovered event (persistent worsening), 74 patients had only censored events (excluded). Groups were similar at baseline, with the recovered group reporting significantly worse symptoms (p<0.01). Recovery group and baseline SGRQ were significant predictors of change in health status over 12 weeks (p=0.04; p<0.01); no effects were observed for lung function. Significant between-group differences in change in respiratory symptom severity from baseline to Week 12 were observed (p<0.01), with the persistent worsening group experiencing clinically meaningful deterioration in breathlessness and chest symptoms. Conclusions: Results suggest some patients have difficulty recovering from symptom-defined exacerbations, leading to a deterioration in health status, dyspnea, and chest symptoms without short-term effects on lung function. Further study of symptom-defined exacerbation recovery and health outcomes is warranted.
引用
收藏
页码:27 / 37
页数:11
相关论文
共 50 条
  • [31] A decision tree to assess short-term mortality after an emergency department visit for an exacerbation of COPD: a cohort study
    Cristóbal Esteban
    Inmaculada Arostegui
    Susana Garcia-Gutierrez
    Nerea Gonzalez
    Iratxe Lafuente
    Marisa Bare
    Nerea Fernandez de Larrea
    Francisco Rivas
    José M. Quintana
    Respiratory Research, 16
  • [32] Comparison of two scores for short-term outcomes in patients with COPD exacerbation in the emergency department: the Ottawa COPD Risk Scale and the DECAF score
    Unal, Ali
    Bayram, Basak
    Ergan, Begum
    Can, Kazim
    Ergun, Yagiz Kagan
    Kilinc, Oguz
    ERJ OPEN RESEARCH, 2023, 9 (02)
  • [33] Short-term exposure to air pollution: Associations with lung function and inflammatory markers in non-smoking, healthy adults
    Dauchet, Luc
    Hulo, Sebastien
    Cherot-Kornobis, Nathalie
    Matran, Regis
    Amouyel, Philippe
    Edme, Jean-Louis
    Giovannelli, Jonathan
    ENVIRONMENT INTERNATIONAL, 2018, 121 : 610 - 619
  • [34] Evaluating the impact of short-term nitrate-rich dietary supplementation on endothelial function in COPD: A randomized crossover study
    Delacoste, Fernanda Beatriz Costa
    Goulart, Cassia da Luz
    Guidoti, Augusto Baumhardt
    Turck, Patrick
    Eibel, Bruna
    Irigoyen, Maria Claudia
    de Araujo, Cintia Laura Pereira
    Dal Lago, Pedro
    RESPIRATORY MEDICINE, 2024, 232
  • [35] Differences in health status between long-term and short-term benzodiazepine users
    Zandstra, SM
    Furer, JW
    van de Lisdonk, EH
    Bor, JHJ
    Zitman, FG
    van Weel, C
    BRITISH JOURNAL OF GENERAL PRACTICE, 2002, 52 (483) : 805 - 808
  • [36] Physical status, symptoms and health-related quality of life during a severe exacerbation of COPD: Recovery and discriminative capacity for future events
    Quadflieg, Kirsten
    Machado, Ana
    de Lima, Fabiano Francisco
    Dederen, Anand
    Daenen, Marc
    Ruttens, David
    Thomeer, Michiel
    Spruit, Martijn A.
    Burtin, Chris
    RESPIRATORY MEDICINE, 2023, 220
  • [37] Short-term benefit of smoking cessation along with glycopirronium on lung function and respiratory symptoms in mild COPD patients: a retrospective study
    Pezzuto, Aldo
    Stellato, Marco
    Catania, Giovanna
    Mazzara, Calogero
    Tonini, Sara
    Caricato, Marco
    Crucitti, Pierfilippo
    Tonini, Giuseppe
    JOURNAL OF BREATH RESEARCH, 2018, 12 (04)
  • [38] Short-term exposure to relative humidity and lung health in early adolescents
    Nassikas, Nicholas J.
    Ni, Wenli
    Rifas-Shiman, Sheryl L.
    Luttmann-Gibson, Heike
    Synn, Andrew
    Oken, Emily
    Gold, Diane R.
    Rice, Mary B.
    ENVIRONMENTAL EPIDEMIOLOGY, 2025, 9 (02) : e371
  • [39] Association of high PM2.5 levels with short-term and medium-term lung function recovery in patients with pulmonary lobectomy
    Liu, Yi-tong
    Xiao, Yi
    Huang, Jian
    Hu, Hao
    Wang, Xina
    Chen, Yueming
    Huang, Zhiqing
    Yang, Xiongwen
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [40] Short-term and long-term follow-up of pulmonary function in patients with COPD after total laryngectomy: A prospective study
    Schoenwald, Charlotte
    Koerber, Maria Isabel
    Beutner, Dirk
    Pfister, Roman
    Frank, Konrad
    Guntinas-Lichius, Orlando
    Michels, Guido
    LARYNGOSCOPE, 2017, 127 (09) : 2045 - 2049